ANPAC

Fresh2 Group (formerly known as AnPac Bio-Medical Science, 安派科生物医学科技(上海)有限公司) is a company that develops diagnostic technologies for the oncology sector. Its products include early cancer risk assessment, pan-cancer screening, and the third immune defense test. The company operates in the fields of nanotechnology, biophysics, and biomedical research.